Kontinuirani monitoring glukoze – nova dijagnostička procedura za postavljanje dijagnoze hiperglikemije belog mantila i potencijalno nekih drugih entiteta

  • Milovan M Stojanović Institut za lečenje i rehabilitaciju Niška Banja
  • Milica Pešić
  • Stevan Ilic
  • Marina Deljanin Ilic
DOI: https://doi.org/10.5937/afmnai40-37498
Ključne reči: šećerna bolest, kontinuirani monitoring glukoze, hiperglikemija belog mantila, ambulatorni monitoring krvnog pritiska

Sažetak


N/A

Reference


  1. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-104. doi: 10.1093/eurheartj/ehy339

  2. American Diabetes Association. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S85-S99. doi: 10.2337/dc21-S007. PMID: 33298418.

  3. Lind M, Polonsky W, Hirsch IB, et al. Continuous Glucose Monitoring vs. Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial. JAMA. 2017;317(4):379-87. doi: 10.1001/jama.2016

  4. Bolinder J, Antuna R, Geelhoed-Duijvestijn P, et al. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016;388(10057):2254-63. doi: 10.1016/S0140-6736(16)31535-5

  5. Messaaoui A, Tenoutasse S, Crenier L. Flash Glucose Monitoring Accepted in Daily Life of Children and Adolescents with Type 1 Diabetes and Reduction of Severe Hypoglycemia in Real-Life Use. Diabetes Technol Ther. 2019;21(6):329-35. doi: 10.1089/dia.2018.0339

  6. American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S73-S84. doi: 10.2337/dc21-S006

  7. Campbell LV, Ashwell SM, Borkman M, et al. White coat hyperglycaemia: disparity between diabetes clinic and home blood glucose concentrations. BMJ. 1992;305(6863):1194-6. doi: 10.1136/bmj.305.6863.1194.

  8. Bloomfield DA, Park A. Decoding white coat hypertension. World J Clin Cases. 2017;5(3):82-92. doi: 10.12998/wjcc.v5.i3.82.

  9. Stojanovic, M. The treatment of masked (uncontrolled) hypertension—Should psychiatrists be involved? The European Journal of Psychiatry 2021.

  10. Rand JS, Kinnaird E, Baglioni A, et al. Acute stress hyperglycemia in cats is associated with struggling and increased concentrations of lactate and norepinephrine. J Vet Intern Med. 2002;16(2):123-32. doi: 10.1892/0891-6640(2002)016<0123:ashici>2.3.co;2

  11. Akirov A, Diker-Cohen T, Masri-Iraqi H, et al. High Glucose Variability Increases Mortality Risk in Hospitalized Patients. J Clin Endocrinol Metab. 2017;102(7):2230-41. doi: 10.1210/jc.2017-00450.

  12. Lardinois CK. 'White coat' hyperglycemia. Arch Fam Med. 1994;3(5):461-4. doi: 10.1001/archfami.3.5.461.

  13. Stojanovic M, Deljanin-Ilic M, Ilic S, et al. Isolated nocturnal hypertension: an unsolved problem-when to start treatment and how low should we go? J Hum Hypertens. 2020;34(10):739-40. doi: 10.1038/s41371-020-00403-5.

  14. Hui P, Zhao L, Xie Y, et al. Nocturnal Hypoxemia Causes Hyperglycemia in Patients With Obstructive Sleep Apnea and Type 2 Diabetes Mellitus. Am J Med Sci. 2016;351(2):160-8. doi: 10.1016/j.amjms.2015.12.002

  15. Rybicka M, Krysiak R, Okopień B. The dawn phenomenon and the Somogyi effect - two phenomena of morning hyperglycaemia. Endokrynol Pol. 2011;62(3):276-84.

Objavljeno
2025/12/09
Broj časopisa
Vol. 40 Br. 1 (2023): Acta facultatis medicae Naissensis
Rubrika
Profesionalni rad / Professional article